ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2026
Microbiological safety and antimicrobial resistance in cashew-based plant-based cheese analogues.
Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
The demand for plant-based cheese analogues has increased in recent years, driven both by the growing adoption of vegan and vegetarian diets and by consumers seeking plant-based alternatives to animal-derived products. Their production relies on diverse raw materials and often incorporates fermentation processes involving molds, yeasts, and lactic acid bacteria (LAB). Within this context, ensuring food safety, including the antimicrobial resistance (AMR) aspects, is essential due to the complex microbial communities involved in fermentation. Therefore, this study investigated the presence of bacterial species of potential public health relevance and assessed AMR profiles and genes in plant-based cheese analogues acquired in Brazil. None of the samples tested positive for Salmonella spp., coagulase-positive Staphylococcus, or Escherichia coli, while Bacillus cereus was detected in one sample. Two atypical colonies recovered on selective media for Salmonella were identified as Cronobacter malonaticus and Delftia acidovorans. Most samples exhibited high mold and yeast counts, likely associated with fermentation and maturation processes. Among 176 LAB isolates, 11 species were identified by MALDI-TOF, and twenty representative strains were selected for antimicrobial susceptibility testing. Resistance was detected in a limited number of isolates, mainly to ciprofloxacin, tetracycline, and gentamicin, whereas C. malonaticus exhibited resistance to penicillin. Whole-genome sequencing was performed on Lactiplantibacillus plantarum, Levilactobacillus brevis, Leuconostoc mesenteroides, Enterococcus faecium, and C. malonaticus. A total of eight antimicrobial resistance genes were identified, four of which were located on plasmids in C. malonaticus and L. brevis. These findings suggest that microorganisms associated with plant-based cheese analogues may act as reservoirs of antimicrobial resistance determinants, highlighting the importance of safety assessment and microbiological surveillance of strains intended for technological or probiotic applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.